Over-50s and vulnerable urged to book ‘Covid-19’ DNA-manipulating ‘vaccine’ before ‘stocks dry up’ in latest desperate attempt to manipulate compliance with a jab that’s already killed many
The national medical director for the NHS is urging the over-50s and those at risk to book their Covid-19 vaccines quickly before slots dry up.
Professor Stephen Powis called on anyone who qualifies for a jab but has not yet received a first dose to book an appointment in the next few days.
The NHS is expecting a slowdown in UK vaccine supply for the whole of April, meaning medics will concentrate on delivering second doses, with fewer first appointments available.
NHS England has said no first appointments should be booked for people under the age of 50 unless they fall into a higher priority group, such as those who are clinically vulnerable.
Prof Powis said: “It is a testament to the careful planning and sheer hard work of staff that the NHS vaccination programme is continuing to protect people against coronavirus at a record pace.
“I was thrilled to get my first dose earlier this month, it was quick, painless and safe and it feels great knowing I’ve got protection against Covid-19 – so if you are eligible, do not delay, book a jab.”
Read more: Over-50s and vulnerable urged to book ‘Covid-19’ DNA-manipulating ‘vaccine’ before ‘stocks dry up’ in latest desperate attempt to manipulate compliance with a jab that’s already killed many
Vaccine hesitancy rises in France after AstraZeneca suspension
Vaccine hesitancy has risen sharply in France since European countries chose to suspend the Oxford/AstraZeneca jab, Euronews reports. Both the European Medical Agency and the World Health Organisation have insisted the vaccine is safe and effective in protecting against Covid-19.
A number of European nations have resumed using the jab, but Norway and Denmark have extended their suspensions. Around 42% of French respondents thought the AstraZeneca jab unsafe in a YouGov survey last month.
But after the suspensions, that figure has now climbed to more than 60%. Euronews asked for the thoughts of some people in the French city of Lyon. “There is some mixed information about the efficacy and side effects, so I am not really sure. I would prefer to get the Pfizer vaccine,” one man said.
“I am afraid of that [AstraZeneca] vaccine,” said a woman who is getting the Pfizer vaccine next month.
Read More: Vaccine hesitancy rises in France after AstraZeneca suspension
'COVID’ Cases Spiking In 13 US States – Most Have High Vaccination Rates
The world is focused on COVID-19 vaccination and the increase in alleged COVID variants that are causing governments to feel they are in a race against time to vaccinate their populations before more variants can be created that may be unpredictable.
COVID cases in 13 US states are
spiking, among these states are some of the most highly vaccinated states in the country. An
Axios analysis found Michigan is leading in new cases as their 7 day average has spiked by around 53%. Michigan also happens to be above the average US vaccination rate at
13.9%.
Why It Matters:
As these numbers continue to be reported, we notice that cases is still the main focus. I was able to find a small uptick in
hospitalizations reported in Michigan, but this did not seem concerning given the level of cases being reported. Most of the time throughout COVID in the US, cases have not been linked to a large spike in hospitalizations.
Many who have ventured outside mainstream media’s tight control on the COVID narrative have hypothesized that strictly focusing on cases does not tell a full picture of what’s going on. Simply testing a person who is found to have COVID isn’t necessarily a negative – in fact, asymptomatic infection may be exactly what the population needs to build herd immunity.
Read more:
COVID Cases Spiking In 13 US States – Most Have High Vaccination Rates
COVID-19: Up to 60m vaccine doses to be manufactured at Barnard Castle, Boris Johnson says
The GSK facility is in the same town notably visited by the prime minister’s former chief aide Dominic Cummings last year. Up to 60 million doses of COVID vaccine will be manufactured at Barnard Castle in the North East, Boris Johnson has announced.
The prime minister revealed that the Novavax jab – which has yet to be approved – will undergo its “fill and finish” stage at a GlaxoSmithKline (GSK) facility. Part of the vaccine is already being produced in the North East, at a Fujifilm site in Billingham, Stockton-on-Tees, as it awaits approval from the Medicines and Healthcare products Regulatory Agency (MHRA).
The GSK facility – which will undertake the final step of the Novavax vaccine’s manufacture from as early as May – is in the same County Durham town that was notably visited by the prime minister’s former chief aide Dominic Cummings last year.Advertisement
The visit to Barnard Castle saw Mr Cummings, who has since departed Number 10, accused of breaching lockdown rules – but he claimed he had made the journey as a means of testing his eyesight.
Read More: Up to 60m vaccine doses to be manufactured at Barnard Castle, Boris Johnson says
Clueless system-serving celebrities now target black community with vaccine propaganda. Lenny Henry leads campaign to drive vaccine uptake in ethnic minority communities saying he hears their ‘legitimate worries and concerns’ but people must ‘trust the facts’. They ARE you silly man – that’s why they’re not having it
Film stars Chiwetel Ejiofor and Thandie Newton, author Malorie Blackman and radio DJ Trevor Nelson are among the signatories of an open letter by Sir Lenny Henry urging black Britons to get the Covid-19 vaccine.
In the letter Sir Lenny acknowledges the ‘legitimate worries and concerns’ that people feel, adding: ‘We know change needs to happen and that it’s hard to trust some institutions and authorities.’ He continues: ‘But we’re asking you to trust the facts about the vaccine from our own professors, doctors, scientists involved in the vaccine’s development, GPs, not just in the UK but across the world including the Caribbean and Africa.
‘Many of whom are our relatives, many of whom have made the ultimate sacrifice to protect the people of this country from this pandemic.’ Older people from black African backgrounds are more than seven times as likely as white British people to have not received a coronavirus vaccine, according to the Office for National Statistics (ONS).
Read More: Sir Lenny Henry leads star-studded campaign to drive vaccine uptake in ethnic minority communities
Teen Diagnosed With Guillain-Barré Weeks After First COVID Vaccine
The previously healthy teenager said he believes the vaccine caused him to develop the rare neurological disorder, but doctors said it could just be a coincidence.
A Texas teenager diagnosed with Guillain-Barré syndrome (GBS) a few weeks after his first dose of the COVID-19 vaccine said he believes the vaccine is to blame, according to a local Houston news channel KPRC2 report. “I wanted to get the vaccine,” said Wyatt McGlaun, a high school senior from The Woodlands. “I felt it was the right thing to do. I wanted to travel and enjoy my last summer before college.”
A few weeks after receiving the vaccine, McGlaun became weak and had difficulty walking. He was admitted to CHI St. Luke’s Health where he was diagnosed with GBS.
News reports didn’t disclose which COVID vaccine McGlaun received. According to Mayo Clinic, GBS is a rare disorder in which the body’s immune system attacks its nerves. Initial symptoms include weakness and tingling in the extremities which can quickly spread, eventually paralyzing the whole body. Most people with the condition must be hospitalized to receive treatment.
People with GBS usually experience their most significant weakness within two weeks after symptoms begin. According to the National Institute of Health, one case of GBS was reported in February in an 82-year-old woman who had one dose of Pfizer’s COVID vaccine.
According to data from the Vaccine Adverse Events Reporting System (VAERS), there have been 70 reported cases of GBS after having received a COVID vaccine with 59% occurring with Pfizer, 44% with Moderna and 3% with Johnson & Johnson (J&J).
Read More: Teen Diagnosed With Guillain-Barré Weeks After First COVID Vaccine